Ondansetron ODT 8 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F9NF0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,684
Award facts
- Contract value 100% obligated
- $11,683.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 27, 2026, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Ondansetron ODT (orally disintegrating tablet) 8 mg in quantities of 30 tablets, with a ceiling value of $11,683.67 and an ultimate completion date of January 28, 2026. The contract utilizes firm fixed-price pricing and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The awardee is a subsidiary of Cencora, Inc., a prominent healthcare solutions provider registered in the System for Award Management.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. This prime vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling the company to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The DLA Troop Support Medical supply chain relies on such contracts to ensure consistent availability of essential medications to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9NF0?
SPE2DR26F9NF0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F9NF0 worth?
The government has obligated $11,684 on SPE2DR26F9NF0.
Is contract SPE2DR26F9NF0 an order under another contract?
Yes. SPE2DR26F9NF0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NF0 competed?
The extent of competition for SPE2DR26F9NF0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award